NDC 50436-0289

bupropion

Bupropion Hydrochloride

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Unit Dose Services. The primary component is Bupropion Hydrochloride.

Product ID50436-0289_cec7d664-178c-4ef1-87d8-8eeaf782b9d9
NDC50436-0289
Product TypeHuman Prescription Drug
Proprietary Namebupropion
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2014-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA202304
Labeler NameUnit Dose Services
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50436-0289-2

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50436-0289-2)
Marketing Start Date2019-02-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50436-0289-1 [50436028901]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-21

NDC 50436-0289-2 [50436028902]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-21

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:25e92816-5015-45be-9b6c-17277ab16515
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993518
  • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]
    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "bupropion" or generic name "Bupropion Hydrochloride"

    NDCBrand NameGeneric Name
    68001-264bupropionbupropion
    68382-353bupropionbupropion
    68382-354bupropionbupropion
    68788-7249bupropionbupropion
    68788-9255bupropionbupropion
    70518-1644bupropionbupropion
    71335-0801bupropionbupropion
    71335-0785bupropionbupropion
    0615-8262bupropionbupropion
    43547-288bupropionbupropion
    43547-289bupropionbupropion
    43547-290bupropionbupropion
    50090-3854bupropionbupropion
    50436-0289bupropionbupropion
    55700-644bupropionbupropion
    63187-521bupropionbupropion
    65841-780bupropionbupropion
    65841-836bupropionbupropion
    70934-151bupropionbupropion
    63629-8036bupropionbupropion
    68788-7283bupropionbupropion
    68071-5214bupropionbupropion
    70518-2641bupropionbupropion
    51655-357bupropionbupropion
    71335-1622bupropionbupropion
    0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0185-0410Bupropion HydrochlorideBupropion Hydrochloride
    0185-0415Bupropion HydrochlorideBupropion Hydrochloride
    0185-1111Bupropion HydrochlorideBupropion Hydrochloride
    0173-0135WELLBUTRINbupropion hydrochloride
    0173-0722WELLBUTRINbupropion hydrochloride
    0173-0947WELLBUTRINbupropion hydrochloride
    0173-0556ZYBANbupropion hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.